Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - witness: Difference between revisions

From GxPlex

Jump to: navigation, search
↠Older edit
m 1 revision imported
m 1 revision imported
 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{#set:
{{ReferenceData
|HasDocument=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|has_document=Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
|RefScope=HM
|module=3
|RefDocPart=Glossary - witness
|unit=3.1.1
|RefLanguage=EN
|scope=HM
|RefTagsEN=
|doc_part=Glossary - witness
|RefTagsOriginal=
|language=EN
|RefTagsFR=
|entry_by=Florian Adragna
|contributors=
|tags=TAG-00312-Imp-isi ++ TAG-00244-Def-ini ++ TAG-00029-Inf-rte ++ TAG-00149-Sig-nds
|tags_display=[[Glossary:TAG-00312-Imp-isi|Impartial witness]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00029-Inf-rte|Informed consent]], [[Glossary:TAG-00149-Sig-nds|Signature]]
|comment=Definition and role of impartial witness
|content=witness
A person who will not be influenced in any way by those who are involved in the clinical trial, who is present and may provide assistance if required when the subject’s informed consent is obtained, and documents that this consent is given freely by signing and dating the informedconsent form.
}}
}}
== Document Information ==
{{:Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995}}
== Reference Details ==
{| class="wikitable" style="width:100%;"
|-
! scope="row" style="width:200px;" | Scope
| HM
|-
! scope="row" style="width:200px;" | Document part
| Glossary - witness
|-
! scope="row" style="width:200px;" | Language
| EN
|-
! scope="row" style="width:200px;" | Original entry by
| Florian Adragna
|-
! scope="row" style="width:200px;" | Contributors
|
|-
! scope="row" style="width:200px;" | Tags (EN)
|
|-
! scope="row" style="width:200px;" | Tags (original language)
|
|-
! scope="row" style="width:200px;" | Tags (FR)
|
|-
! scope="row" | Comment
| Definition and role of impartial witness
|}
== Text ==
witness
A person who will not be influenced in any way by those who are involved in the clinical trial, who is present and may provide assistance if required when the subject’s informed consent is obtained, and documents that this consent is given freely by signing and dating the informedconsent form.

Latest revision as of 13:49, 16 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 3 — Unit 3.1.1
Scope HM
Document part Glossary - witness
Language EN
Original entry by Florian Adragna
Contributors
Tags Impartial witness, Definition, Informed consent, Signature

Content

witness A person who will not be influenced in any way by those who are involved in the clinical trial, who is present and may provide assistance if required when the subject’s informed consent is obtained, and documents that this consent is given freely by signing and dating the informedconsent form.

Retrieved from "https://gxplex.org/index.php?title=Reference:WHO_WHO_-_Guidelines_for_GCP_for_trials_on_pharmaceutical_products*_1995_Glossary_-_witness&oldid=18105"